Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Breast (Edinburgh, Scotland)|March 13, 2012
Inter- and intra-tumoral heterogeneity in DNA damage evaluated by comet assay in early breast cancer patientsFrancesca Galardi, Catherine Oakman, Maria Caterina Truglia, et al.
Cancer Research|October 21, 2010
Prognostic and therapeutic implications of distinct kinase expression patterns in different subtypes of breast cancerGiampaolo Bianchini, Takayuki Iwamoto, Yuan Qi, et al.
The Oncologist|September 28, 2013
DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypesLibero Santarpia, Takayuki Iwamoto, Angelo Di Leo, et al.
Breast Cancer Research : BCR|December 4, 2016
An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancersGiulia Bottai, Carlotta Raschioni, Agnese Losurdo, et al.
Endocrine-Related Cancer|October 16, 2013
A miRNA signature associated with human metastatic medullary thyroid carcinomaLibero Santarpia, George A Calin, Liana Adam, et al.
Cancer Research|December 18, 2015
miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast CancerBrian D Adams, Vikram B Wali, Christopher J Cheng, et al.
Cancer|February 29, 2012
Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patientsEun-Jung Jung, Libero Santarpia, Juyeon Kim, et al.
EMBO Molecular Medicine|December 21, 2013
Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breastAlessandra Rustighi, Alessandro Zannini, Luca Tiberi, et al.
Oncotarget|October 10, 2015
MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patientsLeticia De Mattos-Arruda, Giulia Bottai, Paolo G Nuciforo, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2008
Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumorsCamilo Jimenez, Maria E Cabanillas, Libero Santarpia, et al.
Pageof 7